nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A2—nephron—focal segmental glomerulosclerosis	0.0459	0.295	CbGeAlD
Pramipexole—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0367	0.236	CbGeAlD
Pramipexole—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.0157	0.0226	CcSEcCtD
Pramipexole—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0219	CcSEcCtD
Pramipexole—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.02	CcSEcCtD
Pramipexole—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.02	CcSEcCtD
Pramipexole—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0189	CcSEcCtD
Pramipexole—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0189	CcSEcCtD
Pramipexole—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0184	CcSEcCtD
Pramipexole—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0164	CcSEcCtD
Pramipexole—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0164	CcSEcCtD
Pramipexole—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0164	CcSEcCtD
Pramipexole—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.016	CcSEcCtD
Pramipexole—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.015	CcSEcCtD
Pramipexole—SLC22A2—nephron tubule—focal segmental glomerulosclerosis	0.00991	0.0638	CbGeAlD
Pramipexole—SLC22A2—kidney—focal segmental glomerulosclerosis	0.00871	0.0561	CbGeAlD
Pramipexole—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.00859	0.0124	CcSEcCtD
Pramipexole—SLC22A2—cortex of kidney—focal segmental glomerulosclerosis	0.00848	0.0546	CbGeAlD
Pramipexole—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00821	0.0118	CcSEcCtD
Pramipexole—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00821	0.0118	CcSEcCtD
Pramipexole—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00809	0.0117	CcSEcCtD
Pramipexole—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00752	0.0484	CbGeAlD
Pramipexole—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00735	0.0106	CcSEcCtD
Pramipexole—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00735	0.0106	CcSEcCtD
Pramipexole—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.00984	CcSEcCtD
Pramipexole—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.0094	CcSEcCtD
Pramipexole—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.0094	CcSEcCtD
Pramipexole—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0091	CcSEcCtD
Pramipexole—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0091	CcSEcCtD
Pramipexole—SLC22A1—kidney—focal segmental glomerulosclerosis	0.00615	0.0396	CbGeAlD
Pramipexole—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.00881	CcSEcCtD
Pramipexole—HTR1D—kidney—focal segmental glomerulosclerosis	0.0061	0.0392	CbGeAlD
Pramipexole—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00872	CcSEcCtD
Pramipexole—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.00815	CcSEcCtD
Pramipexole—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00808	CcSEcCtD
Pramipexole—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.00552	0.0355	CbGeAlD
Pramipexole—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00793	CcSEcCtD
Pramipexole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.00786	CcSEcCtD
Pramipexole—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.00759	CcSEcCtD
Pramipexole—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.0074	CcSEcCtD
Pramipexole—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0051	0.00734	CcSEcCtD
Pramipexole—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00508	0.0327	CbGeAlD
Pramipexole—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00728	CcSEcCtD
Pramipexole—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00728	CcSEcCtD
Pramipexole—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00728	CcSEcCtD
Pramipexole—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00723	CcSEcCtD
Pramipexole—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00679	CcSEcCtD
Pramipexole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00669	CcSEcCtD
Pramipexole—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.0066	CcSEcCtD
Pramipexole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.00655	CcSEcCtD
Pramipexole—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.00651	CcSEcCtD
Pramipexole—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.00646	CcSEcCtD
Pramipexole—ADRA2C—kidney—focal segmental glomerulosclerosis	0.00446	0.0287	CbGeAlD
Pramipexole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00637	CcSEcCtD
Pramipexole—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00633	CcSEcCtD
Pramipexole—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00633	CcSEcCtD
Pramipexole—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00629	CcSEcCtD
Pramipexole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00629	CcSEcCtD
Pramipexole—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00435	0.028	CbGeAlD
Pramipexole—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0062	CcSEcCtD
Pramipexole—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0062	CcSEcCtD
Pramipexole—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00616	CcSEcCtD
Pramipexole—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00616	CcSEcCtD
Pramipexole—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00612	CcSEcCtD
Pramipexole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00601	CcSEcCtD
Pramipexole—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00601	CcSEcCtD
Pramipexole—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00582	CcSEcCtD
Pramipexole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.00572	CcSEcCtD
Pramipexole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.00562	CcSEcCtD
Pramipexole—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00555	CcSEcCtD
Pramipexole—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00552	CcSEcCtD
Pramipexole—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00552	CcSEcCtD
Pramipexole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00546	CcSEcCtD
Pramipexole—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00543	CcSEcCtD
Pramipexole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.00537	CcSEcCtD
Pramipexole—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00525	CcSEcCtD
Pramipexole—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00522	CcSEcCtD
Pramipexole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00522	CcSEcCtD
Pramipexole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.00517	CcSEcCtD
Pramipexole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.00511	CcSEcCtD
Pramipexole—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.00347	0.0223	CbGeAlD
Pramipexole—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00496	CcSEcCtD
Pramipexole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00486	CcSEcCtD
Pramipexole—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00477	CcSEcCtD
Pramipexole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00468	CcSEcCtD
Pramipexole—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00464	CcSEcCtD
Pramipexole—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00464	CcSEcCtD
Pramipexole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00464	CcSEcCtD
Pramipexole—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00462	CcSEcCtD
Pramipexole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.0046	CcSEcCtD
Pramipexole—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00451	CcSEcCtD
Pramipexole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00448	CcSEcCtD
Pramipexole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00444	CcSEcCtD
Pramipexole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00442	CcSEcCtD
Pramipexole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0044	CcSEcCtD
Pramipexole—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00438	CcSEcCtD
Pramipexole—HTR2A—kidney—focal segmental glomerulosclerosis	0.00303	0.0195	CbGeAlD
Pramipexole—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00436	CcSEcCtD
Pramipexole—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00434	CcSEcCtD
Pramipexole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00431	CcSEcCtD
Pramipexole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00427	CcSEcCtD
Pramipexole—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00425	CcSEcCtD
Pramipexole—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00425	CcSEcCtD
Pramipexole—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00423	CcSEcCtD
Pramipexole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00415	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00412	CcSEcCtD
Pramipexole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00408	CcSEcCtD
Pramipexole—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00408	CcSEcCtD
Pramipexole—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00393	CcSEcCtD
Pramipexole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.0038	CcSEcCtD
Pramipexole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00379	CcSEcCtD
Pramipexole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00375	CcSEcCtD
Pramipexole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00374	CcSEcCtD
Pramipexole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00367	CcSEcCtD
Pramipexole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00366	CcSEcCtD
Pramipexole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00361	CcSEcCtD
Pramipexole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00359	CcSEcCtD
Pramipexole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00352	CcSEcCtD
Pramipexole—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00345	CcSEcCtD
Pramipexole—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00344	CcSEcCtD
Pramipexole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00335	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00333	CcSEcCtD
Pramipexole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00331	CcSEcCtD
Pramipexole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00326	CcSEcCtD
Pramipexole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00324	CcSEcCtD
Pramipexole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00324	CcSEcCtD
Pramipexole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00322	CcSEcCtD
Pramipexole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0032	CcSEcCtD
Pramipexole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0032	CcSEcCtD
Pramipexole—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00319	CcSEcCtD
Pramipexole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00315	CcSEcCtD
Pramipexole—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00314	CcSEcCtD
Pramipexole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00313	CcSEcCtD
Pramipexole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00313	CcSEcCtD
Pramipexole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00311	CcSEcCtD
Pramipexole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00311	CcSEcCtD
Pramipexole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00305	CcSEcCtD
Pramipexole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00302	CcSEcCtD
Pramipexole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00302	CcSEcCtD
Pramipexole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.003	CcSEcCtD
Pramipexole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00288	CcSEcCtD
Pramipexole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00286	CcSEcCtD
Pramipexole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00285	CcSEcCtD
Pramipexole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00284	CcSEcCtD
Pramipexole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00282	CcSEcCtD
Pramipexole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00281	CcSEcCtD
Pramipexole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00277	CcSEcCtD
Pramipexole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00268	CcSEcCtD
Pramipexole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00266	CcSEcCtD
Pramipexole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0026	CcSEcCtD
Pramipexole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00259	CcSEcCtD
Pramipexole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00258	CcSEcCtD
Pramipexole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00254	CcSEcCtD
Pramipexole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00252	CcSEcCtD
Pramipexole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0025	CcSEcCtD
Pramipexole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00246	CcSEcCtD
Pramipexole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00245	CcSEcCtD
Pramipexole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00245	CcSEcCtD
Pramipexole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00243	CcSEcCtD
Pramipexole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.0024	CcSEcCtD
Pramipexole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00236	CcSEcCtD
Pramipexole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00234	CcSEcCtD
Pramipexole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00232	CcSEcCtD
Pramipexole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00231	CcSEcCtD
Pramipexole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0023	CcSEcCtD
Pramipexole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00225	CcSEcCtD
Pramipexole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00225	CcSEcCtD
Pramipexole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00224	CcSEcCtD
Pramipexole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00218	CcSEcCtD
Pramipexole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00217	CcSEcCtD
Pramipexole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00216	CcSEcCtD
Pramipexole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00213	CcSEcCtD
Pramipexole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00213	CcSEcCtD
Pramipexole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00213	CcSEcCtD
Pramipexole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00212	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00211	CcSEcCtD
Pramipexole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0021	CcSEcCtD
Pramipexole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00208	CcSEcCtD
Pramipexole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00206	CcSEcCtD
Pramipexole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00204	CcSEcCtD
Pramipexole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00203	CcSEcCtD
Pramipexole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.002	CcSEcCtD
Pramipexole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.002	CcSEcCtD
Pramipexole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00198	CcSEcCtD
Pramipexole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00197	CcSEcCtD
Pramipexole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00194	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00186	CcSEcCtD
Pramipexole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00184	CcSEcCtD
Pramipexole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00183	CcSEcCtD
Pramipexole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00182	CcSEcCtD
Pramipexole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00181	CcSEcCtD
Pramipexole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0018	CcSEcCtD
Pramipexole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00177	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00176	CcSEcCtD
Pramipexole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00176	CcSEcCtD
Pramipexole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00174	CcSEcCtD
Pramipexole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00174	CcSEcCtD
Pramipexole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00168	CcSEcCtD
Pramipexole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00167	CcSEcCtD
Pramipexole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00162	CcSEcCtD
Pramipexole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00161	CcSEcCtD
Pramipexole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00161	CcSEcCtD
Pramipexole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0015	CcSEcCtD
Pramipexole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00146	CcSEcCtD
Pramipexole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00144	CcSEcCtD
Pramipexole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.0014	CcSEcCtD
Pramipexole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000936	0.00135	CcSEcCtD
Pramipexole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.0013	CcSEcCtD
Pramipexole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.00129	CcSEcCtD
Pramipexole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.00128	CcSEcCtD
Pramipexole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.00128	CcSEcCtD
Pramipexole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.00121	CcSEcCtD
Pramipexole—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000114	0.00076	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000113	0.000753	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000113	0.000752	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000113	0.000751	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000113	0.000749	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000112	0.000746	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000112	0.000745	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000112	0.000745	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000111	0.00074	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000111	0.000736	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000111	0.000734	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00011	0.000733	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00011	0.00073	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00011	0.00073	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00011	0.000729	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00011	0.000728	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00011	0.000727	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000108	0.000719	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000108	0.000716	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000107	0.000712	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000107	0.000711	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000107	0.00071	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.000703	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000106	0.000701	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000106	0.0007	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000105	0.000699	CbGpPWpGaD
Pramipexole—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000105	0.000699	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000105	0.000696	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000105	0.000694	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000104	0.000692	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000104	0.000688	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000103	0.000686	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000103	0.000685	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000103	0.000683	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000102	0.00068	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000102	0.000679	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000102	0.000678	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000102	0.000677	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000102	0.000676	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000102	0.000675	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000101	0.000669	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000101	0.000667	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0001	0.000667	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.0001	0.000666	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	9.98e-05	0.000662	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.87e-05	0.000655	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.84e-05	0.000653	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.84e-05	0.000653	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.79e-05	0.00065	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.69e-05	0.000643	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CTGF—focal segmental glomerulosclerosis	9.68e-05	0.000643	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.59e-05	0.000636	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.52e-05	0.000632	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.51e-05	0.000632	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.5e-05	0.00063	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	9.42e-05	0.000625	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	9.41e-05	0.000624	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.37e-05	0.000622	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.36e-05	0.000621	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.35e-05	0.000621	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9.32e-05	0.000618	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	9.29e-05	0.000617	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.25e-05	0.000614	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	9.24e-05	0.000613	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.19e-05	0.00061	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	9.12e-05	0.000606	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CTGF—focal segmental glomerulosclerosis	9.02e-05	0.000599	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9e-05	0.000597	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	9e-05	0.000597	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.97e-05	0.000595	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.95e-05	0.000594	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.92e-05	0.000592	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.92e-05	0.000592	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.92e-05	0.000592	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.87e-05	0.000589	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.86e-05	0.000588	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.77e-05	0.000582	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.72e-05	0.000579	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.7e-05	0.000578	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	8.69e-05	0.000577	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.68e-05	0.000576	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.68e-05	0.000576	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.64e-05	0.000573	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.63e-05	0.000573	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.6e-05	0.000571	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	8.6e-05	0.000571	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	8.58e-05	0.00057	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	8.52e-05	0.000565	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.5e-05	0.000564	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.46e-05	0.000562	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.46e-05	0.000561	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.45e-05	0.000561	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.31e-05	0.000552	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.17e-05	0.000542	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	8.13e-05	0.000539	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.97e-05	0.000529	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.9e-05	0.000525	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.9e-05	0.000524	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.87e-05	0.000523	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.87e-05	0.000522	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.83e-05	0.00052	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.8e-05	0.000518	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.79e-05	0.000517	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.77e-05	0.000516	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.77e-05	0.000515	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.75e-05	0.000514	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	7.73e-05	0.000513	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.7e-05	0.000511	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	7.65e-05	0.000508	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.63e-05	0.000507	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.56e-05	0.000502	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.51e-05	0.000498	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.5e-05	0.000498	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.46e-05	0.000495	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.4e-05	0.000491	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.29e-05	0.000484	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.25e-05	0.000482	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.17e-05	0.000476	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.17e-05	0.000476	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.16e-05	0.000475	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	7.16e-05	0.000475	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.1e-05	0.000471	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.07e-05	0.000469	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.06e-05	0.000468	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.05e-05	0.000468	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.05e-05	0.000468	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.01e-05	0.000465	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.01e-05	0.000465	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.96e-05	0.000462	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.9e-05	0.000458	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.86e-05	0.000455	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.82e-05	0.000453	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.76e-05	0.000449	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—LPL—focal segmental glomerulosclerosis	6.71e-05	0.000445	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.69e-05	0.000444	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.67e-05	0.000443	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.64e-05	0.00044	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.59e-05	0.000437	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.58e-05	0.000437	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.56e-05	0.000435	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	6.53e-05	0.000433	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.49e-05	0.000431	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.48e-05	0.00043	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.47e-05	0.00043	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.47e-05	0.000429	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.42e-05	0.000426	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.33e-05	0.00042	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—LPL—focal segmental glomerulosclerosis	6.25e-05	0.000415	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.23e-05	0.000414	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.21e-05	0.000412	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.13e-05	0.000407	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.02e-05	0.0004	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.02e-05	0.0004	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.98e-05	0.000397	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.95e-05	0.000395	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.92e-05	0.000393	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.89e-05	0.000391	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.85e-05	0.000388	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.84e-05	0.000388	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.81e-05	0.000386	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.78e-05	0.000384	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.76e-05	0.000382	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AGT—focal segmental glomerulosclerosis	5.74e-05	0.000381	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.64e-05	0.000374	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.63e-05	0.000373	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.61e-05	0.000372	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.61e-05	0.000372	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	5.58e-05	0.000371	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.54e-05	0.000367	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.53e-05	0.000367	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.5e-05	0.000365	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.46e-05	0.000362	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.43e-05	0.00036	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.39e-05	0.000358	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AGT—focal segmental glomerulosclerosis	5.35e-05	0.000355	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.34e-05	0.000355	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.31e-05	0.000353	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	5.3e-05	0.000352	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.19e-05	0.000344	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.17e-05	0.000343	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.12e-05	0.00034	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.1e-05	0.000339	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.02e-05	0.000333	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5e-05	0.000332	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.97e-05	0.00033	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.97e-05	0.00033	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.95e-05	0.000329	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.87e-05	0.000323	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.87e-05	0.000323	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.83e-05	0.00032	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.8e-05	0.000319	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.79e-05	0.000318	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.69e-05	0.000311	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.67e-05	0.00031	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.62e-05	0.000307	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.62e-05	0.000306	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.57e-05	0.000304	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.57e-05	0.000303	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	4.54e-05	0.000301	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.46e-05	0.000296	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.44e-05	0.000294	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.43e-05	0.000294	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—focal segmental glomerulosclerosis	4.41e-05	0.000292	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.31e-05	0.000286	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.31e-05	0.000286	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	4.29e-05	0.000284	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.26e-05	0.000283	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.24e-05	0.000281	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.2e-05	0.000279	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.17e-05	0.000277	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—focal segmental glomerulosclerosis	4.11e-05	0.000273	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.1e-05	0.000272	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.91e-05	0.00026	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.85e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.84e-05	0.000255	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.81e-05	0.000253	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.79e-05	0.000252	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.73e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.71e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.69e-05	0.000245	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.67e-05	0.000244	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.59e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.5e-05	0.000233	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.5e-05	0.000233	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	3.48e-05	0.000231	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.3e-05	0.000219	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.26e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.26e-05	0.000216	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.21e-05	0.000213	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.14e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.07e-05	0.000204	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.03e-05	0.000201	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.94e-05	0.000195	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.92e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.89e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.84e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.83e-05	0.000188	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.75e-05	0.000183	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.72e-05	0.000181	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.69e-05	0.000178	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.5e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.46e-05	0.000163	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.43e-05	0.000161	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.34e-05	0.000155	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.33e-05	0.000155	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.27e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.23e-05	0.000148	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.06e-05	0.000136	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.02e-05	0.000134	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.84e-05	0.000122	CbGpPWpGaD
